web-banner-marketing2

Market Leads & Opportunities

United Kingdom-Newcastle Upon Tyne: Manufacture and supply of Pramipexole and matching placebo for clinical trial looking at use in patients with treatment resistant bipolar depression.

Type of document: Contract Awards
Country: United Kingdom
OJEU Ref: (2018/S 163-372400/EN)
Nature of contract: Supply contract
Procedure: Open procedure
Regulation of procurement: EU – with participation by GPA countries
Type of bid required: Not applicable

Contract award notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: Northumberland, Tyne & Wear NHS Foundation Trust
Postal address: St Nicholas Hospital, Jubilee Road
Town: Newcastle Upon Tyne
Postal code: NE3 3XT
Country: United Kingdom
Contact Person: Mr Gavin Thompson
Telephone: +44 1912232778
Email: gavin.thompson@ntw.nhs.uk
Internet address(es):
Main address:
Address of the buyer profile:

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Manufacture and supply of Pramipexole and matching placebo for clinical trial looking at use in patients with treatment resistant bipolar depression.

Reference number: DN337166
II.1.2) Main CPV code: 33000000
II.1.3) Type of contract Supplies
II.1.4) Short Description: Northumberland, Tyne and Wear NHS Foundation Trust (NTW) have successfully bid for a HTA funding to run a National, multi-site, placebo controlled clinical trial looking a pramipexole use in 290 patients with treatment resistant bipolar depression. This will require the manufacture of matching placebo tablets to pramipexole and the blinding of active pramipexole tablets.
The trial will be run by the Regional Affective Disorders Outpatient Service. This is a specialist/tertiary level affective disorders service which provides care for patients with complex and/or treatment refractory affective disorders and other treatment refractory conditions complicated by an affective component.
NB: please note that this is an award notice not a new opportunity.
II.1.6) Information about lots:
The contract is divided into lots: no
II.1.7) Total value of the procurement(excluding VAT)
Value:232867
Currency:GBP
II.2) Description
II.2.3) Place of performance
Nuts code: UKC
II.2.4) Description of the procurement
Award notice concerning the recent tender for the manufacture of matching placebo tablets to pramipexole and the blinding of active pramipexole tablets.

II.2.5)Award criteria

II.2.11) Information about options
Options no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
Section V: Award of contract
Contract No: DN337166
Title: Manufacture and supply of Pramipexole and matching placebo for clinical trial looking at use in patients with treatment resistant bipolar depression.

A contract/lot is awarded yes
V.2) Award of contract
V.2.1) Date of conclusion of the contract:2018-07-20
V.2.2) Information about tenders
Number of tenders received:
V.2.3) Name and address of the contractor
Official name: Modepharma Limited
Postal address: 114 Barnfield Wood Road
Town: Beckenham
Postal code: BR3 6SX
Country: United Kingdom
Nuts code: UKC
The contractor is an SME yes

V.2.4) Information on value of the contract/lot(excluding VAT)
Total value of the contract/lot:232867
Currency:GBP

Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Official name: Northumberland, Tyne and Wear NHS Foundation Trust
Postal address: St Nicholas Hospital, Jubilee Road, Gosforth
Town: Newcastle upon Tyne
Postal code: NE3 3XT
Country: United Kingdom

VI.5) Date of dispatch of this notice:
2018-08-24